Credit Suisse Starts Durata Therapeutics (DRTX) at Outperform
Get Alerts DRTX Hot Sheet
Price: $24.16 --0%
Rating Summary:
5 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 23
Rating Summary:
5 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 10 | New: 23
Join SI Premium – FREE
Credit Suisse initiates coverage on Durata Therapeutics (NASDAQ: DRTX) with a Outperform. PT $13.00.
For an analyst ratings summary and ratings history on Durata Therapeutics click here. For more ratings news on Durata Therapeutics click here.
Shares of Durata Therapeutics closed at $7.86 yesterday.
For an analyst ratings summary and ratings history on Durata Therapeutics click here. For more ratings news on Durata Therapeutics click here.
Shares of Durata Therapeutics closed at $7.86 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barclays Starts Centrus Energy Corp. (LEU) at Equalweight
- Ladenburg Thalmann Starts Editas Medicine (EDIT) at Buy
- Evercore ISI Starts Equity Residential (EQR) at In Line
Create E-mail Alert Related Categories
New CoverageRelated Entities
Credit SuisseSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share